Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile
Author:
Affiliation:
1. Queen's University Kingston; Kingston ON Canada
2. Baxalta Innovations GmbH; Vienna Austria
3. Baxalta US Inc.; Milford MA USA
4. Emory University School of Medicine; Atlanta GA USA
Funder
National Institutes of Health
Hemophilia of Georgia, Inc
Baxalta US Inc
Publisher
Wiley
Subject
Genetics (clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12784/fullpdf
Reference54 articles.
1. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group;Lusher;N Engl J Med,1993
2. Acquired factor VIII inhibitors: pathophysiology and treatment;Ma;Hematology Am Soc Hematol Educ Program,2006
3. Acquired haemophilia A: a 2013 update;Franchini;Thromb Haemost,2013
4. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry;Baudo;Blood,2012
5. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A;Collins;J Thromb Haemost,2009
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A;International Journal of Hematology;2024-08-19
2. Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents;Seminars in Thrombosis and Hemostasis;2024-06-12
3. Advances and challenges in the purification of recombinant coagulation factors: A review;Journal of Chromatography A;2024-02
4. Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasma;Research and Practice in Thrombosis and Haemostasis;2024-01
5. Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa;Diagnostics;2022-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3